Fuse Science

Fuse Science EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Fuse Science (DROP) as of Oct 10, 2026 is 12.84 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 99.98 % — a change of -87.15% (lower).

EBIT/Assets

12.84 %

YoY

-87.15%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Fuse Science is 2023 12.84 % . Operating Income to Assets Ratio (EBIT/Assets) of Fuse Science was 2022 99.98 % . It decreases by -87.15% lower compared to the previous year.

The Fuse Science EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2014
-45,757.58 USD
Jan 1, 2015
-21,674.54 USD
Jan 1, 2021
-97,988.55 USD
Jan 1, 2022
99.98 USD
Jan 1, 2023
12.84 USD
The Fuse Science EBIT/Assets history
YEAREBIT/AssetsYoY
12.84 %-87.15%
99.98 %-100.10%
-97,988.55 %+352.09%
-21,674.54 %-52.63%
-45,757.58 %—
Access this data via the Eulerpool API

Fuse Science Stock analysis

What does Fuse Science do? Fuse Science Inc. is a US-based company that focuses on the development and marketing of innovative technologies in the health and sports sector. The company was founded in 2008 and is headquartered in Miami Beach, Florida. History Fuse Science was founded by Brian Tuffin, who aimed to enhance the performance of athletes and fitness enthusiasts. In 2012, the company gained worldwide recognition by signing internationally renowned golfer Tiger Woods as its brand ambassador. This not only increased the company's visibility but also demonstrated its ability to attract stars in the sports world. Business model Fuse Science has an innovative business model for marketing and distributing its products. The company specializes in the production and marketing of products based on patented technologies. A crucial component of the business model is collaborating with well-known athletes and sports clubs. These ambassadors help portray the company's products as more consumer-friendly and credible. Another vital distribution channel is online commerce. Segments Fuse Science offers products in various segments: 1) Sports nutrition The sports nutrition segment includes a wide range of products, such as energy bars, gels, drinks, and supplements, aimed at improving athletes' performance and accelerating their post-workout recovery. 2) Pharmaceuticals Fuse Science also has a pharmaceutical segment focusing on the development of novel drugs. The company utilizes its patented technology to deliver medications faster into the body and enhance their effectiveness. An example of such a medication is Tegison, used in the treatment of severe skin conditions. 3) Cosmetics Fuse Science also offers a broad range of cosmetic products. These products aim to improve skin appearance and reduce wrinkles. Products Fuse Science has a variety of products on the market that rely on its patented technology. Some of the most well-known products include: 1) ElectroFuse ElectroFuse is an electrolyte drink that helps rehydrate the body after physical exertion. 2) PowerFuse PowerFuse is a dietary supplement aimed at improving athletes' performance and accelerating their post-workout recovery. 3) LipriSe LipriSe is a cream that helps reduce the appearance of wrinkles and age spots. Conclusion Fuse Science is an innovative company specializing in the development and marketing of products based on its patented technology. The company markets its products in both the sports and medical fields, aiming to enhance athletes' performance and improve people's overall health. Fuse Science has a promising future in developing new products that contribute to improving people's health and well-being. Fuse Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fuse Science stock

Operating Income to Assets Ratio (EBIT/Assets) of Fuse Science is 12.84 % in 2023.

Operating Income to Assets Ratio (EBIT/Assets) of Fuse Science changed from 99.98 % to 12.84 %, representing a -87.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Fuse Science since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Fuse Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

Profitability — Fuse Science

All Key Metrics — Fuse Science